Kesong Peng

1.8k total citations · 1 hit paper
28 papers, 1.3k citations indexed

About

Kesong Peng is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Kesong Peng has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Cell Biology. Recurrent topics in Kesong Peng's work include Epigenetics and DNA Methylation (7 papers), Histone Deacetylase Inhibitors Research (3 papers) and Sphingolipid Metabolism and Signaling (3 papers). Kesong Peng is often cited by papers focused on Epigenetics and DNA Methylation (7 papers), Histone Deacetylase Inhibitors Research (3 papers) and Sphingolipid Metabolism and Signaling (3 papers). Kesong Peng collaborates with scholars based in China, United States and Canada. Kesong Peng's co-authors include Chundong Yu, Pingli Mo, Guang Liang, Ming Li, Xiaokun Li, Huiping Zhou, Wengang Li, Yunjie Zhao, Yong Pan and Runping Liu and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Journal of Cell Biology.

In The Last Decade

Kesong Peng

28 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lactylation stabilizes TFEB to elevate autophagy and lysosomal activity

2024 44 citations Gan Luo, Kesong Peng et al. The Journal of Cell Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kesong Peng China	21	730	293	199	192	180	28	1.3k
Liu Gao-lin China	22	610 0.8×	163 0.6×	155 0.8×	103 0.5×	241 1.3×	56	1.4k
Xiaojie Ma China	23	762 1.0×	140 0.5×	233 1.2×	199 1.0×	190 1.1×	68	1.5k
Ke Wu China	21	800 1.1×	189 0.6×	134 0.7×	142 0.7×	227 1.3×	86	1.5k
Ying Sun China	24	1.1k 1.4×	379 1.3×	178 0.9×	124 0.6×	392 2.2×	93	2.1k
Shan Lin China	18	502 0.7×	162 0.6×	129 0.6×	122 0.6×	155 0.9×	90	1.2k
Łukasz Mateuszuk Poland	24	490 0.7×	134 0.5×	209 1.1×	191 1.0×	94 0.5×	54	1.4k
Susen Becker Germany	21	554 0.8×	202 0.7×	140 0.7×	157 0.8×	147 0.8×	36	1.2k
Antje Ludwig Germany	24	1.2k 1.7×	227 0.8×	230 1.2×	121 0.6×	200 1.1×	54	2.0k
Xinchun Zhou United States	22	1.1k 1.6×	243 0.8×	179 0.9×	188 1.0×	517 2.9×	62	1.9k
Yijun Deng United States	18	1.0k 1.4×	116 0.4×	150 0.8×	175 0.9×	174 1.0×	31	1.7k

Countries citing papers authored by Kesong Peng

Since Specialization

Citations

This map shows the geographic impact of Kesong Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kesong Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kesong Peng more than expected).

Fields of papers citing papers by Kesong Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kesong Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kesong Peng. The network helps show where Kesong Peng may publish in the future.

Co-authorship network of co-authors of Kesong Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Kesong Peng. A scholar is included among the top collaborators of Kesong Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kesong Peng. Kesong Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Luo, Gan, Kesong Peng, Yusha Wang, et al.. (2024). Lactylation stabilizes TFEB to elevate autophagy and lysosomal activity. The Journal of Cell Biology. 223(11). 44 indexed citations breakdown →

Mu, Qingchun, Madiha Zahra Syeda, Qian Cheng, et al.. (2024). Neutrophil Targeting Platform Reduces Neutrophil Extracellular Traps for Improved Traumatic Brain Injury and Stroke Theranostics. Advanced Science. 11(21). e2308719–e2308719. 41 indexed citations

Lu, Yuting, Yang Li, Xiaoling Zhu, et al.. (2023). Nano-immunotherapy for lung cancer. SHILAP Revista de lepidopterología. 2(1). e9130018–e9130018. 20 indexed citations

Chen, Qiang, Peng Guo, Pingli Mo, et al.. (2022). Demethylase JMJD2D induces PD-L1 expression to promote colorectal cancer immune escape by enhancing IFNGR1-STAT3-IRF1 signaling. Oncogene. 41(10). 1421–1433. 22 indexed citations

Chen, Qiang, Kesong Peng, Junjia Liu, et al.. (2022). Nuclear receptor coactivator SRC-1 promotes colorectal cancer progression through enhancing GLI2-mediated Hedgehog signaling. Oncogene. 41(20). 2846–2859. 19 indexed citations

Peng, Kesong, et al.. (2021). Correction to: Histone demethylase JMJD2D activates HIF1 signaling pathway via multiple mechanisms to promote colorectal cancer glycolysis and progression. Oncogene. 40(12). 2336–2337. 20 indexed citations

Peng, Kesong, Ming Li, Pingli Mo, et al.. (2020). Inflammation-induced JMJD2D promotes colitis recovery and colon tumorigenesis by activating Hedgehog signaling. Oncogene. 39(16). 3336–3353. 34 indexed citations

Peng, Kesong, et al.. (2020). Histone demethylase JMJD2D activates HIF1 signaling pathway via multiple mechanisms to promote colorectal cancer glycolysis and progression. Oncogene. 39(47). 7076–7091. 32 indexed citations

Peng, Kesong, Yu Li, Ming Li, et al.. (2018). Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice. Gastroenterology. 156(4). 1112–1126. 84 indexed citations

10.

Peng, Kesong, Guoqiang Su, Pingli Mo, et al.. (2018). Histone demethylase JMJD1A promotes colorectal cancer growth and metastasis by enhancing Wnt/β-catenin signaling. Journal of Biological Chemistry. 293(27). 10606–10619. 51 indexed citations

11.

Peng, Kesong, Mengzhen Li, Liping Qin, et al.. (2017). Histone demethylase JMJD1A promotes urinary bladder cancer progression by enhancing glycolysis through coactivation of hypoxia inducible factor 1α. Oncogene. 36(27). 3868–3877. 90 indexed citations

12.

Wang, Yongqing, Hiroaki Aoki, Jing Yang, et al.. (2017). The role of sphingosine 1‐phosphate receptor 2 in bile‐acid–induced cholangiocyte proliferation and cholestasis‐induced liver injury in mice. Hepatology. 65(6). 2005–2018. 177 indexed citations

13.

Tong, Zhangwei, Kesong Peng, Wei Wang, et al.. (2016). Histone acetyl transferase GCN5 promotes human hepatocellular carcinoma progression by enhancing AIB1 expression. Cell & Bioscience. 6(1). 47–47. 43 indexed citations

14.

Peng, Kesong, Yong Pan, Jieli Li, et al.. (2016). 11β-Hydroxysteroid Dehydrogenase Type 1(11β-HSD1) mediates insulin resistance through JNK activation in adipocytes. Scientific Reports. 6(1). 37160–37160. 28 indexed citations

15.

Qian, Yuanyuan, Yali Zhang, Peng Zhong, et al.. (2016). Inhibition of inflammation and oxidative stress by an imidazopyridine derivative X22 prevents heart injury from obesity. Journal of Cellular and Molecular Medicine. 20(8). 1427–1442. 30 indexed citations

16.

Skibba, Melissa, Yuanyuan Qian, Yuyan Bao, et al.. (2016). New EGFR inhibitor, 453, prevents renal fibrosis in angiotensin II-stimulated mice. European Journal of Pharmacology. 789. 421–430. 19 indexed citations

17.

Pan, Yong, Kesong Peng, Jieli Li, et al.. (2015). Inhibition of 11β-HSD1 by LG13 improves glucose metabolism in type 2 diabetic mice. Journal of Molecular Endocrinology. 55(2). 119–131. 9 indexed citations

18.

Wu, Xudong, Yunzhou Li, Kesong Peng, & Huiping Zhou. (2014). HIV protease inhibitors in gut barrier dysfunction and liver injury. Current Opinion in Pharmacology. 19. 61–66. 15 indexed citations

19.

Liang, Guang, Yali Zhang, Xin Jiang, et al.. (2014). Discovery and evaluation of novel anti-inflammatory derivatives of natural bioactive curcumin. Drug Design Development and Therapy. 8. 2161–2161. 24 indexed citations

20.

Nagahashi, Masayuki, Kazuaki Takabe, Runping Liu, et al.. (2014). Conjugated bile acid–activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression. Hepatology. 61(4). 1216–1226. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact